Jopan DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Pantoprazole 40 mg, designed for the management of gastrointestinal disorders. Domperidone, a dopamine D2 receptor antagonist, facilitates gastric motility by enhancing the movement of the stomach and intestines, thereby alleviating symptoms such as nausea, vomiting, bloating, and gastric discomfort. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The synergistic action of these two agents makes Jopan DSR Capsule particularly beneficial in treating conditions characterized by delayed gastric emptying and excessive acid production. It is typically prescribed for patients experiencing dyspepsia, acid reflux, and gastroparesis, improving both motility and acid control. The medication should be taken as directed by a healthcare professional, usually before meals, to optimize therapeutic outcomes. Caution is advised in patients with known hypersensitivity to either component, and it is contraindicated in those with prolactinoma or severe liver impairment. Regular monitoring and adherence to prescribed dosages are essential to minimize potential adverse effects and ensure efficacy.